Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPortmeirion Regulatory News (PMP)

Share Price Information for Portmeirion (PMP)

Share Price is delayed by 15 minutes
Get Live Data
51.50    0.00 (0.00%)
Bid:
50.00
Ask:
53.00
Spread: 3.00 (6.00%)
Market Cap: £24.61m
PMP Live PriceLast checked at - London Stock Exchange

Intraday Portmeirion Share Chart

Investor results presentation

2 Sep 2021 07:00

RNS Number : 4606K
Portmeirion Group PLC
02 September 2021
 

Portmeirion Group PLC 

Investor results presentation

Portmeirion Group PLC, the designer, manufacturer and worldwide distributor of high quality homewares under the Portmeirion, Spode, Royal Worcester, Pimpernel, Wax Lyrical and Nambé brands, is pleased to announce that Mike Raybould, Chief Executive and David Sproston, Group Finance Director, will provide a live presentation relating to Interim Results for the six months to 30 June 2021 via the Investor Meet Company platform on 16th Sep 2021 at 10:00am BST.

The presentation is open to all existing and potential shareholders. Questions can be submitted pre-event via your Investor Meet Company dashboard up until 9am the day before the meeting or at any time during the live presentation.

Investors can sign up to Investor Meet Company for free and add to meet Portmeirion Group PLC, via:

https://www.investormeetcompany.com/portmeirion-group-plc/register-investor

Investors who already follow Portmeirion Group PLC, on the Investor Meet Company platform will automatically be invited.

 ENQUIRIES: 

 Portmeirion Group PLC:

 Mike Raybould

+44 (0) 1782 743 443

mraybould@portmeiriongroup.com

 Chief Executive

 David Sproston

 

+44 (0) 1782 743 443

 

dsproston@portmeiriongroup.com

 Group Finance Director

 

 Hudson Sandler:

 Dan de Belder

+44 (0) 207 796 4133

ddebelder@hudsonsandler.com

 Nick Moore

nmoore@hudsonsandler.com

 

 Panmure Gordon (UK) Limited

 (Nominated Adviser and Broker):

 

+44 (0) 207 886 2500

 Freddy Crossley

Corporate Finance

 Rupert Dearden

Corporate Broking

 

 Singer Capital Markets

 (Joint Broker):

 

+44 (0) 207 496 3000

Peter SteelRachel Hayes

Investment Banking

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLGDCRUGDGBB
Date   Source Headline
23rd Jun 20264:32 pmRNSPDMR Shareholdings
23rd Jun 202611:36 amRNSResult of General Meeting and Total Voting Rights
10th Jun 20267:00 amRNSResult of Retail Offer
4th Jun 20268:00 amRNSProposed Retail Offer
4th Jun 20267:00 amRNSResult of Placing and Notice of General Meeting
3rd Jun 20264:40 pmRNSProposed Placing to raise at least £15 million
2nd Jun 20261:02 pmRNSAGM Resolutions
27th May 20263:08 pmRNSExercise of Options and Total Voting Rights
21st May 20263:30 pmRNS-RStatement re Government support for UK ceramics
11th May 202610:00 amRNSConfirmation of Director Appointment
6th May 20267:01 amRNSPreliminary Results
6th May 20267:00 amRNSDirectorate change
20th Apr 202612:10 pmRNSHolding(s) in Company
27th Feb 202610:37 amRNSHolding(s) in Company
12th Feb 20263:48 pmRNSNotification of Major Holdings
12th Feb 20263:38 pmRNSNotification of Major Holdings
3rd Feb 20267:00 amRNSFY 2025 Trading Update
8th Jan 20261:03 pmRNSHolding(s) in Company
8th Dec 20257:00 amRNS-RSenior strategic hires
6th Oct 20251:37 pmRNSInvestor Presentation via Investor Meet Company
25th Sep 20257:00 amRNSInterim results for the six months to 30 June 2025
21st Jul 20257:00 amRNSH1 2025 TRADING UPDATE
3rd Jun 20257:00 amRNSExercise of Options, PDMR & Voting Rights
20th May 20252:24 pmRNSAGM Resolutions
11th Apr 20257:00 amRNSAnnual Report & Accounts and Notice of AGM
7th Apr 20257:00 amRNSDirector's Dealing
2nd Apr 202512:04 pmRNSDirector's Dealing
2nd Apr 20257:20 amRNSDirector's Dealing
1st Apr 202511:39 amRNSDirector's Dealing
31st Mar 20257:00 amRNSPreliminary Results
17th Mar 20257:00 amRNSNotice of Results and Investor Presentation
6th Mar 20255:14 pmRNSHolding(s) in Company
20th Jan 20257:00 amRNSAppointment of Non-Executive Chairman
20th Dec 202410:02 amRNSHolding(s) in Company
17th Dec 20247:00 amRNSHolding(s) in Company
13th Dec 20247:00 amRNSTrading Update
28th Oct 20243:07 pmRNSHolding(s) in Company
1st Oct 20247:00 amRNSAppointment to the Board
19th Sep 20247:00 amRNSInterim Results
10th Sep 20247:00 amRNSNotice of Interim Results
9th Sep 20249:40 amRNSHolding(s) in Company
6th Sep 20247:00 amRNSAppointment of Group Finance Director
18th Jul 20247:00 amRNSH1 2024 Trading update
21st May 20242:01 pmRNSAGM Resolutions
21st May 20247:00 amRNSWithdrawal of AGM Resolutions 14 and 15
8th May 20247:00 amRNSGrant of Options
17th Apr 20247:00 amRNSAnnual Report & Accounts and Notice of AGM
4th Apr 20242:41 pmRNSHolding(s) in Company
27th Mar 20247:00 amRNSNotice of Investor Presentation
17th Jan 20247:00 amRNSFY23 Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.